Activation of Human Vascular Endothelial Cells by IFN-γ: Acquisition of HLA Class II Expression, TSST-1-Binding Activity and Accessory Activity in T Cell Activation by the Toxin

1991 ◽  
Vol 96 (1) ◽  
pp. 55-61 ◽  
Author(s):  
Minako Araake ◽  
Takehiko Uchiyama ◽  
Ken’ichi Imanishi ◽  
Xiao-Jie Yan
2014 ◽  
Vol 34 (suppl_1) ◽  
Author(s):  
Jing Zhou ◽  
Lingfeng Qin ◽  
Tai Yi ◽  
Rahmat Ali ◽  
Qingle Li ◽  
...  

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in transplant patients. The mechanisms underlying increased recipient CVD are poorly understood. We have established an animal model of transplant-associated recipient CVD by combining murine models of atherosclerosis (apolipoprotein E-deficient recipients, ApoE -/- ) and of transplant rejection (heterotopic cardiac transplantation). Mice were placed on a normal chow diet for 3 months after transplantation and then analyzed. ApoE -/- recipients of rejecting allografts developed more severe aortic atherosclerosis compared to syngeneic controls, most strikingly across a major histocompatibility complex (MHC) class II antigen barrier (Fig. A). Atherosclerotic lesions were associated with increased CD4 + T cell infiltration and sustained CD4 + T cell activation as assessed by flow cytometry. Total cholesterol and triglyceride levels were unchanged. Cardiac function and aortic distention by echocardiography demonstrated significant impairment in recipients of MHC class II mismatched grafts (Fig. B). In addition, quantitative assessment of proinflammatory cytokines demonstrated significantly elevated plasma levels of interferon (IFN)-γ, the signature Th1 cytokine, as well as IFN-γ inducer cytokine IL-12 in mice with MHC class II mismatched grafts. Our study provides an experimental model of transplant-associated recipient CVD, reveals the critical role of sustained CD4 + T cell activation by donor-recipient immunological crosstalk, and has the potential for identifying novel therapeutic interventions for transplant-associated recipient CVD.


2010 ◽  
Vol 40 (3) ◽  
pp. 733-743 ◽  
Author(s):  
Beatrice Bolinger ◽  
Daniel Engeler ◽  
Philippe Krebs ◽  
Simone Miller ◽  
Sonja Firner ◽  
...  

2008 ◽  
Vol 90 (2) ◽  
pp. 170-174 ◽  
Author(s):  
O. PUGLIESE ◽  
M. VIORA ◽  
B. CAMPONESCHI ◽  
P. CORDIALI FEI ◽  
F. CAPRILLI ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Björn B. Hofmann ◽  
Nicolas Krapp ◽  
Yingchun Li ◽  
Carolina De La Torre ◽  
Marloes Sol ◽  
...  

AbstractIFNγ enhances allograft immunogenicity and facilitates T-cell mediated rejection. This may cause interstitial fibrosis and tubular atrophy (IFTA), contributing to chronic allograft loss. We assessed if inhibition of T-cell activation by N-octanoyl dopamine (NOD) impairs adherence of activated T-cells to endothelial cells and the ability of activated T-cells to produce IFNγ. We also assessed if NOD affects IFNγ mediated gene expression in endothelial cells. The presence of NOD during T-cell activation significantly blunted their adhesion to unstimulated and cytokine stimulated HUVEC. Supernatants of these T-cells displayed significantly lower concentrations of TNFα and IFNγ and were less capable to facilitate T-cell adhesion. In the presence of NOD VLA-4 (CD49d/CD29) and LFA-1 (CD11a/CD18) expression on T-cells was reduced. NOD treatment of IFNγ stimulated HUVEC reduced the expression of MHC class II transactivator (CIITA), of MHC class II and its associated invariant chain CD74. Since IFTA is associated with T-cell mediated rejection and IFNγ to a large extent regulates immunogenicity of allografts, our current data suggest a potential clinical use of NOD in the treatment of transplant recipients. Further in vivo studies are warranted to confirm these in vitro findings and to assess the benefit of NOD on IFTA in clinically relevant models.


Blood ◽  
1997 ◽  
Vol 89 (11) ◽  
pp. 4128-4135 ◽  
Author(s):  
Neil A. Fanger ◽  
Chunlei Liu ◽  
Paul M. Guyre ◽  
Kathleen Wardwell ◽  
Jerome O'Neil ◽  
...  

Abstract The primary function of polymorphonuclear neutrophils (PMN) in the immune response appears to be acute phagocytic clearance of foreign pathogens and release of inflammatory mediators. Consistent with their assumed lack of major histocompatibility complex (MHC) class II expression, PMN have not been considered to play a role in antigen presentation and T-cell activation. However, recent reports have shown that human PMN can express MHC class II molecules both in vitro and in vivo after stimulation with either granulocyte-macrophage colony-stimulating factor (GM-CSF ) or interferon-γ (IFN-γ). Thus, under appropriate conditions, PMN could play a significant role in immune regulation, including T-cell activation. In this report, we demonstrate that human class II–expressing PMN can serve as accessory cells in superantigen (SAg)-mediated T-cell activation. This accessory activity for SAg presentation was present only after induction of MHC class II expression, and was especially pronounced following culture of PMN with GM-CSF plus IFN-γ, which acted synergistically to induce MHC class II molecules on PMN. Moreover, the level of MHC class II expression and the magnitude of SAg-induced T-cell responses were found to be highly correlated and distinctly donor dependent, with PMN from some donors repeatedly showing fivefold higher responses than PMN from other donors. On the other hand, culture of PMN with GM-CSF plus IFN-γ under conditions that resulted in optimal MHC class II expression did not enable them to function as antigen-presenting cells for either intact tetanus toxoid (TT) or for a TT peptide. These results delineate a new pathway for T-cell activation by SAg that may play an important role in the severity of SAg-induced inflammatory responses. They also identify a donor-specific polymorphism for induction of PMN MHC class II expression which may be of significance for therapies involving GM-CSF and IFN-γ.


Sign in / Sign up

Export Citation Format

Share Document